Company Overview of Kindred Biosciences, Inc.
Key Executives for Kindred Biosciences, Inc.
|Richard Chin M.D.||98 Relationships||Co-Founder, Chief Executive Officer, President, Interim Chief Financial Officer and Director||50|
|Denise M. Bevers||No Relationships||Co-Founder, Chief Operating Officer and Secretary||50|
|Stephen Sundlof D.V.M., Ph.D.||No Relationships||Chief Scientific Officer and Executive Vice President of Regulatory Affairs & Quality||66|
|Jennifer Elliott||No Relationships||Vice President of Legal Affairs and Intellectual Property||--|
|Noe Reyes D.V.M||No Relationships||Medical Director||--|
Kindred Biosciences, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Richard Chin M.D.||98 Relationships||Kindred Biosciences, Inc.||50|
|Ervin Veszpremi||18 Relationships||Kindred Biosciences, Inc.||58|
|Raymond Townsend Pharm.D||3 Relationships||Kindred Biosciences, Inc.||72|
|Herbert D. Montgomery||8 Relationships||The Thomas Kinkade Company, Inc.||74|
Kindred Biosciences, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Herbert D. Montgomery||8 Relationships||3 Executives|
|Compensation Committee Pharm.D||Raymond Townsend||3 Relationships||3 Executives|
|Nominating Committee||Ervin Veszpremi||18 Relationships||3 Executives|
|Corporate Governance Committee||Ervin Veszpremi||18 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$619.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.